Similar articles

• Selective inhibition of monoamine oxidase in rat brain mitochondria.

  Fuller RW, Warren BJ, Molloy BB. Fuller RW, et al. Biochem Pharmacol. 1970 Nov;19(11):2934-6. doi: 10.1016/0006-2952(70)90036-5. Biochem Pharmacol. 1970. PMID: 5512701 No abstract available.
• The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.

  Popov N, Matthies H, Lietz W, Thiemann C, Jassmann E. Popov N, et al. Biochem Pharmacol. 1970 Aug;19(8):2413-8. doi: 10.1016/0006-2952(70)90265-0. Biochem Pharmacol. 1970. PMID: 5520601 No abstract available.
• Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.

  Egashira T, Ekstedt B, Kinemuchi H, Wiberg A, Oreland L. Egashira T, et al. Med Biol. 1976 Aug;54(4):272-7. Med Biol. 1976. PMID: 957813
• [New data on monoamine oxidase inhibitors].

  Gorkin VZ. Gorkin VZ. Vestn Akad Med Nauk SSSR. 1971;26(11):23-8. Vestn Akad Med Nauk SSSR. 1971. PMID: 4942003 Review. Russian. No abstract available.
• Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.

  Neff NH, Yang HY. Neff NH, et al. Life Sci. 1974 Jun 1;14(11):2061-74. doi: 10.1016/0024-3205(74)90089-7. Life Sci. 1974. PMID: 4603266 Review. No abstract available.